Zou Shenqiang, Zhu Xiaofang, Zhang Lirong, Guo Fan, Zhang Miaomiao, Tan Youwen, Gong Aihua, Fang Zhengzou, Ju Huixiang, Wu Chaoyang, Du Fengyi
Department of Hepatosis, The Third people' s Hospital of Zhenjiang, Jiangsu University, 212021, Zhenjiang, People's Republic of China.
School of Medicine, Jiangsu University, 212013, Zhenjiang, People's Republic of China.
Nanoscale Res Lett. 2018 Mar 6;13(1):76. doi: 10.1186/s11671-017-2427-8.
Cerium oxide nanoparticles recently have received extensive attention in biomedical applications due to their excellent anti-oxidation performance. In this study, a simple, mild, and green approach was developed to synthesize cerium-doped carbonaceous nanoparticles (Ce-doped CNPs) using bio-mineralization of bull serum albumin (BSA) as precursor. The resultant Ce-doped CNPs exhibited uniform and ultrasmall morphology with an average size of 14.7 nm. XPS and FTIR results revealed the presence of hydrophilic group on the surface of Ce-doped CNPs, which resulted in excellent dispersity in water. The CCK-8 assay demonstrated that Ce-doped CNPs possessed favorable biocompatibility and negligible cytotoxicity. Using HO-induced reactive oxygen species (ROS) as model, Ce-doped CNPs showed highly hydroxyl radical scavenging capability. Furthermore, flow cytometry and live-dead staining results indicated that Ce-doped CNPs protected cells from HO-induced damage in a dose-dependent effect, which provided a direct evidence for anti-oxidative performance. These findings suggest that Ce-doped CNPs as novel ROS scavengers may provide a potential therapeutic prospect in treating diseases associated with oxidative stress.
近年来,氧化铈纳米颗粒因其优异的抗氧化性能在生物医学应用中受到广泛关注。在本研究中,开发了一种简单、温和且绿色的方法,以牛血清白蛋白(BSA)的生物矿化作为前体来合成铈掺杂碳质纳米颗粒(Ce掺杂CNPs)。所得的Ce掺杂CNPs呈现出均匀且超小的形态,平均尺寸为14.7纳米。X射线光电子能谱(XPS)和傅里叶变换红外光谱(FTIR)结果表明Ce掺杂CNPs表面存在亲水基团,这导致其在水中具有优异的分散性。细胞计数试剂盒-8(CCK-8)检测表明Ce掺杂CNPs具有良好的生物相容性和可忽略不计的细胞毒性。以羟基自由基(HO·)诱导的活性氧(ROS)为模型,Ce掺杂CNPs表现出高度的羟基自由基清除能力。此外,流式细胞术和活死染色结果表明Ce掺杂CNPs以剂量依赖性方式保护细胞免受HO·诱导的损伤,这为其抗氧化性能提供了直接证据。这些发现表明,Ce掺杂CNPs作为新型ROS清除剂可能为治疗与氧化应激相关的疾病提供潜在的治疗前景。